Teradyne Inc. recently reported a significant jump in its fourth-quarter profit, reaching $257.2 million, a substantial increase from $146.3 million a year earlier. This growth, alongside a 44 percent rise in revenue, is largely attributed to robust demand for its semiconductor testing equipment, particularly from customers in the artificial intelligence and automotive sectors. CEO Greg Smith noted that AI demand in compute and memory alone drove over 60 percent of their fourth-quarter revenue, leading to a strong first-quarter forecast and a stock surge of over 20 percent.
Meanwhile, Meta Platforms, despite an underperforming stock in 2025, shows signs of a potential rebound in 2026. The company saw its 2025 revenue increase by 22 percent to $201 million, with an even faster growth forecast of 26 to 34 percent for the first quarter of 2026. Artificial intelligence plays a crucial role here, enhancing ad recommendation algorithms and personalizing ads. Meta is also expanding its advertising reach to WhatsApp and Threads, signaling significant long-term opportunities.
The AI sector continues to attract substantial investment, with companies addressing various needs. Lotus Health secured $35 million to support its free AI doctor service, aiming to make healthcare more accessible. Gruve, a startup launched in 2024, raised $50 million to tackle AI's power demands by connecting unused data center capacity, bringing its total funding to $87.5 million. CEO Tarun Raisoni highlighted power scarcity as AI's biggest challenge, with Gruve currently offering 30 megawatts across four US sites and planning international expansion.
Palantir Technologies stands out as a strong AI investment, leveraging its platforms to analyze vast digital data for government agencies like the Department of Defense and the CDC. The company reported a 63 percent revenue increase in the third quarter, with operating income up 51 percent, indicating sustained growth. In related developments, Vertiv introduced Vertiv Next Predict in January 2026, an AI-powered service designed to predict and prevent issues in data center power, cooling, and IT systems, shifting maintenance from reactive to proactive.
However, the rise of AI also presents challenges for traditional software companies. Wall Street traders are selling off software stocks due to fears that AI will increase competition and lower prices. For instance, shares of legal software firms dropped after AI startup Anthropic released a new productivity tool for lawyers, leading to significant drops in valuations and sector downgrades. On a different note, OpenAI CEO Sam Altman suggested his company might invest in or fund firms using its AI for drug discovery, potentially covering AI model costs in exchange for royalties on new drugs, emphasizing the capital-intensive nature of scientific discovery with AI.
Key Takeaways
- Teradyne's Q4 profit jumped to $257.2 million from $146.3 million, driven by strong AI and automotive demand for semiconductor testing equipment.
- AI demand in compute and memory accounted for over 60% of Teradyne's Q4 revenue, leading to a stock increase of over 20%.
- Meta Platforms' 2025 revenue grew 22% to $201 million, with AI powering ad revenue growth and expansion to WhatsApp and Threads.
- Meta forecasts Q1 2026 revenue growth between 26% and 34%, signaling a potential stock rebound.
- Lotus Health raised $35 million to fund its free AI doctor service, aiming to improve healthcare accessibility.
- Gruve secured $50 million, totaling $87.5 million, to address AI's power needs by connecting unused data center capacity.
- Palantir Technologies reported a 63% Q3 revenue increase, with over half its revenue from government agencies utilizing its AI platforms.
- Vertiv launched Vertiv Next Predict in January 2026, an AI-powered service for predictive data center maintenance.
- Wall Street traders are selling software stocks due to fears that AI, exemplified by Anthropic's new tools, will increase competition and lower prices.
- OpenAI CEO Sam Altman indicated the company might invest in or fund firms using its AI for drug discovery, potentially taking royalties on new drugs.
Teradyne profits jump on strong AI demand
Teradyne Inc. announced a significant increase in its fourth-quarter profit, reaching $257.2 million, or $1.03 per share. This is up from $146.3 million a year earlier. The company's revenue also grew to $1.31 billion, driven by high demand for its semiconductor testing equipment. This demand comes especially from customers working in artificial intelligence and automotive industries. Teradyne's CEO, Greg Smith, expects continued strength in these markets throughout the year.
Teradyne stock soars 12 percent on AI demand
Teradyne's stock rose 12 percent after the company reported strong fourth-quarter earnings. The robotics firm saw a 44 percent increase in revenue compared to last year. CEO Greg Smith stated that artificial intelligence demand in compute and memory drove over 60 percent of their fourth-quarter revenue. Teradyne also gave a strong forecast for the first quarter, expecting revenue between $1.15 billion and $1.25 billion. This shows the growing impact of AI on the tech sector.
Teradyne shares jump over 20 percent on AI forecast
Teradyne Inc. shares rose more than 20 percent after the company gave a strong forecast for its first-quarter revenue and profit. This growth is driven by demand from AI-related data centers. The chip-test equipment maker expects first-quarter revenue between $1.15 billion and $1.25 billion, much higher than analyst predictions. Teradyne's fourth-quarter revenue also jumped 44 percent to $1.083 billion. CEO Greg Smith highlighted AI demand in compute, networking, and memory as key factors for these strong results.
Teradyne beats earnings forecasts with AI chip testing
Teradyne, a robotics and testing equipment company, reported strong fourth-quarter earnings, with revenue jumping 44 percent year over year. This growth was fueled by high demand for AI-related compute and memory testing across the semiconductor industry. The company also provided an aggressive first-quarter forecast, expecting earnings per share between $1.89 and $2.26, well above analyst predictions. Teradyne's equipment is crucial for testing AI accelerators and high-bandwidth memory modules before they ship. This shows the company's vital role in the growing AI supply chain.
Meta stock poised for rebound in 2026
Meta Platforms' stock underperformed in 2025 despite strong operational growth, with revenue increasing 22 percent to $201 million. The company expects even faster revenue growth in the first quarter of 2026, between 26 percent and 34 percent. Artificial intelligence is powering Meta's ad revenue growth by improving recommendation algorithms and creating personalized ads. Meta is also expanding ads to WhatsApp and Threads, presenting a big long-term opportunity. Despite past stock performance, Meta plans to increase investments, showing confidence in its future.
Meta Platforms stock ready for 2026 rebound
Meta Platforms' stock faced a tough year in 2025, but the company showed strong growth, with revenue up 22 percent to $201 million. Meta expects even faster growth in the first quarter of 2026, forecasting revenue to increase by 26 percent to 34 percent. Artificial intelligence is key to this growth, improving ad recommendations and personalizing ads for users. The company is also bringing ads to WhatsApp and Threads, which offers significant future opportunities. Despite past stock performance, Meta is increasing its investments and looks attractively valued for a potential rebound.
Lotus Health secures 35 million for free AI doctor
Lotus Health successfully raised $35 million in funding. This money will support their innovative AI doctor service. The unique aspect of this service is that it offers free consultations to patients. This development aims to make healthcare more accessible through artificial intelligence.
Gruve raises 50 million to power AI growth
Gruve, a startup launched in 2024, raised $50 million to address the power needs of artificial intelligence. The company connects unused data center power in major US cities to support AI inference. CEO Tarun Raisoni, a serial entrepreneur, stated that a lack of power is AI's biggest challenge. This new funding, led by Xora Innovation, brings Gruve's total raised to $87.5 million. Gruve currently offers 30 megawatts across four US sites and plans to expand to Japan and Western Europe.
Palantir Technologies offers strong AI investment
Palantir Technologies is highlighted as a strong artificial intelligence investment, especially compared to SoundHound AI. Palantir's AI-powered platforms help organizations analyze vast amounts of digital data to find unique insights. Over half of its revenue comes from government agencies like the Department of Defense and the CDC, which used Palantir to combat COVID-19. The company reported a 63 percent revenue increase in the third quarter, with operating income up 51 percent. This strong growth is expected to continue, making Palantir an attractive long-term option.
Five AI value stocks for smart investors
Investors looking for artificial intelligence exposure without high prices can consider five value stocks. These companies focus on essential areas like power infrastructure, legacy tech upgrades, and semiconductor components. Company A provides power for AI data centers, while Company B updates older systems with AI. Company C makes vital parts for AI hardware, and Company D manages data crucial for AI development. Finally, Company E uses AI to improve industrial automation, boosting efficiency.
Vertiv launches AI tool for data center care
In January 2026, Vertiv introduced Vertiv Next Predict, a new AI-powered service for data center maintenance. This tool uses artificial intelligence to detect problems, predict issues, and suggest solutions for power, cooling, and IT systems. It helps data centers move from fixing problems after they happen to preventing them, which saves time and money. This innovation strengthens Vertiv's position in supporting complex, AI-driven data centers. Investors will watch how well Next Predict is adopted and its impact on Vertiv's financial performance.
Traders sell software stocks amid AI fears
Wall Street traders are selling off software stocks due to growing fears about artificial intelligence's impact on the industry. Jeffrey Favuzza from Jefferies described the situation as a "SaaSpocalypse." For example, shares of legal software firms dropped after AI startup Anthropic released a new productivity tool for lawyers. Many worry that AI will increase competition, lower prices, and make it easier to replace existing software solutions. This has led to a significant drop in software stock valuations, with some analysts downgrading the sector.
OpenAI may invest in AI drug discovery firms
OpenAI CEO Sam Altman announced that his company might invest in or help fund firms using its artificial intelligence for drug discovery. OpenAI could cover the costs of using its AI models and then receive a royalty from any new drugs found. Altman mentioned this idea at the World Economic Forum in Davos, explaining that scientific discovery with AI will require significant capital. This approach could help OpenAI profit from breakthroughs made with its technology.
Sources
- Teradyne Profit Rises as Sales Surge on AI-Related Demand
- Teradyne stock pops on earnings beat driven by AI demand
- Teradyne stock jumps after hours on AI outlook; TER traders turn to Tuesday call
- Teradyne crushes Q4 earnings on AI chip testing surge
- Can This Artificial Intelligence (AI) Stock Bounce Back in 2026?
- Can This Artificial Intelligence (AI) Stock Bounce Back in 2026?
- Lotus Health nabs $35M for AI doctor that sees patients for free
- Gruve raises $50M to expand AI power infrastructure
- Forget SoundHound AI: This Enterprise AI Name With Deep Government Roots Is the Safer 10X Shot
- Five AI Value Stocks for Investors to Consider
- Should Vertiv’s New AI-Powered Data Center Maintenance Platform Reshape How VRT Investors View Its AI Strategy?
- ‘Get Me Out’: Traders Dump Software Stocks as AI Fears Take Hold
- Altman Says OpenAI May Back Firms Using AI for Drug Discovery
Comments
Please log in to post a comment.